• EE389 Economic Burden of Diagnosed Congenital Cytomegalovirus in the United States and Japan

    Jun 1, 2024, 00:00

  • RWD63 Utilizing AI/ML for Insight Into the Transition Factors From Traditional (Non-Nano Delivery) to Nano Drug Delivery of Paclitaxel in Breast Cancer Patients

    Jun 1, 2024, 00:00

  • MSR96 Real-World Data Integration for Causal Inferen Benefits, Costs, and Case Studies

    Jun 1, 2024, 00:00

  • CO2 Association Between Classes of Antidiabetic Medications and Their Potential Risk or Protective Effects on Cancer: A Systematic Review and Network Meta-Analysis

    Jun 1, 2024, 00:00

  • RWD64 Comorbidities of Irritable Bowel Syndrome in Colombia: A Real-World Data Analysis

    Jun 1, 2024, 00:00

  • SA62 Treatment Patterns Following First Line CDK4/6 Inhibitor Progression in HR+, HER2- Metastatic Breast Cancer

    Jun 1, 2024, 00:00

  • MT43 The Economic Impact of Screening Mammogram Image Quality-Related Retakes and Recalls: A Modeling Study from the Provider Perspective

    Jun 1, 2024, 00:00

  • EE85 Sources of Increased Expenditures for Young Children with Autism Spectrum Disorder Diagnoses in Employer-Sponsored Plans, 2016–2021

    Jun 1, 2024, 00:00

  • HTA45 Comparison of the Use of Real-World Evidence for Clinical Effectiveness in HTA Pre- and Post- Introduction of the NICE Framework – an Update

    Jun 1, 2024, 00:00

  • PCR171 Measuring Disease and Treatment-Related Symptoms and HRQoL Impacts in Patients With High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) Using the EORTC Qlq-C30 and NMIBC-24: Qualitative Literature Review and Gap Analysis

    Jun 1, 2024, 00:00

  • HSD103 Burden of Disease in Patients With Uncontrolled Gout in the USA

    Jun 1, 2024, 00:00

  • EE448 A Recent Adoption of Cost-Effectiveness Thresholds in Brazil and Its Repercussions

    Jun 1, 2024, 00:00

  • CO192 A Retrospective Database Analysis of US Medicaid Treatment-Naive People With HIV (PWH) With or Without Mental Health Disorders (MHDs) Initiating Single-Tablet Regimens (STRs) Vs. Multi-Tablet Regimens (MTRs)

    Jun 1, 2024, 00:00

  • EE70 The Cost of Chronic Lung Allograft Dysfunction (CLAD) in Lung Transplant (LTx) Recipients By Stage 0-4: A Claims Database Analysis

    Jun 1, 2024, 00:00

  • EPH90 Health Characteristics and Adherence Patterns in Electronic Wearable Device Users: A Study in Low- and Middle-Income Countries

    Jun 1, 2024, 00:00

  • EPH1 High Throughput Screening for Roflumilast Adverse Effects in Real-World Settings: A Sequence Symmetry Analysis

    Jun 1, 2024, 00:00

  • MT24 The State of Single-Use Ureteroscopy in the United States

    Jun 1, 2024, 00:00

  • EE479 Adverse Event Costs Associated With Systemic Therapies for Metastatic Colorectal Cancer Previously Treated With Standard Therapies and Biologics in the United States, Italy, Portugal, and Spain

    Jun 1, 2024, 00:00

  • CO69 Burden of Clinical Syndromes Associated with Pneumococcal Disease in Ecuador: A 2019 Perspective

    Jun 1, 2024, 00:00

  • RWD118 Implementation and Validation of a Prioritization Logic to Identify the Best Available Race/Ethnicity Information for Members in Commercial Plans

    Jun 1, 2024, 00:00

  • PCR8 Comparison of the Sociodemographic Characteristics and Various Indicators of Patients with Acute Ischemic Stroke

    Jun 1, 2024, 00:00

  • EE113 Impact of Type 1 Diabetes and Severe Hypoglycemia on Productivity and Out-of-Pocket Costs of Adult Continuous Glucose Monitor Users: Results From a Cross-Sectional Survey in the United States

    Jun 1, 2024, 00:00

  • CO154 Prevalence of Unmet Social Needs and Post-Transplant Outcomes Among Adult Sickle Cell Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

    Jun 1, 2024, 00:00

  • CO198 Exploring Progression-Free Survival 2 (PFS2) Endpoint Trends and Uptake in the US Healthcare Landscape

    Jun 1, 2024, 00:00

  • RWD159 Assessing the Relationship between Initial Opioid Prescription and Subsequent Pain-Related Healthcare Resource Utilization and Costs Among Patients with Chronic Pain

    Jun 1, 2024, 00:00

  • EPH38 Antimicrobial Susceptibility of Klebsiella Pneumoniae Clinical Isolates From the Lower Respiratory Tract Infection During the COVID-19 Pandemic in Brazil (SMART 2020-2021)

    Jun 1, 2024, 00:00

  • HPR83 The Distribution and Influential Factors Analysis of National Price-Negotiated Drugs in Medical Institutions and Pharmacies in China: A Case Study of Hyperkalemia

    Jun 1, 2024, 00:00

  • EPH128 Identifying Diabetic Ketoacidosis Events at Diagnosis Among Type 1 Diabetes Patients in Claims Data

    Jun 1, 2024, 00:00

  • CO120 Progression of Disease Burden Among Boys with Duchenne Muscular Dystrophy (DMD) According to Ambulatory Status and Age at Loss of Ambulation (LoA)

    Jun 1, 2024, 00:00

  • PCR89 Impact of Dosing and Administration on HRQoL Among People With Hemophilia: A Time Trade-Off Study Including 2.250 Respondents in the UK, Canada and the US

    Jun 1, 2024, 00:00

  • EPH85 Machine Learning-Based Prediction of Unplanned Readmission Due to Major Adverse Cardiovascular Events (MACE) Among Hospitalized Patients With Blood Cancers

    Jun 1, 2024, 00:00

  • CO159 Evaluating Risk of Complications in CAR-T Cell Therapy Among Patients with Acute Lymphocytic Leukemia

    Jun 1, 2024, 00:00

  • EE525 Comparative Analysis of Launch Prices for Orphan Drugs in the US and EU4

    Jun 1, 2024, 00:00

  • MSR47 Assessing the Impact of the Prior Distribution for the Within-Study Correlation in Bivariate Network Meta-Analysis: A Case Study in Relapsed/Refractory Multiple Myeloma

    Jun 1, 2024, 00:00

  • EE80 The Health Equity Impact of a Hypothetical Disease-Modifying Treatment for Alzheimer's Disease in the United States: A Distributional Cost-Effectiveness Analysis

    Jun 1, 2024, 00:00

  • RWD2 Comparison of Availability of New Cancer Medicines between Seven Countries

    Jun 1, 2024, 00:00

  • EE50 Estimating the Clinical and Economic Outcomes of Universal Varicella and Herpes Zoster Vaccination in Belgium Using a Dynamic Transmission Model With Dynamic Population

    Jun 1, 2024, 00:00

  • EE351 Economic Evaluation of Botulinum Toxin Type a (XEOMEEN) in the Treatment of Adult Patients With Spasticity in the "IMSS” and “ISSSTE”

    Jun 1, 2024, 00:00

  • EE247 Budget Impact of Infliximab Subcutaneous from the US Healthcare Perspective

    Jun 1, 2024, 00:00

  • HPR94 Clinical Trial Engagement in Hepatocellular Carcinoma: Understanding Demographic and Clinical Characteristics

    Jun 1, 2024, 00:00

  • P58 Clinical Impact of Replacing 13-Valent With a 15-Valent Pneumococcal Conjugate Vaccine in Costa Rican National Immunization Program

    Jun 1, 2024, 00:00

  • CO136 Unmet Treatment Needs in the Management of Patients With Eosinophilic Esophagitis: Insights From a Real-world Survey

    Jun 1, 2024, 00:00

  • Table of Contents

    Jun 1, 2024, 00:00

  • RWD170 Real-World Experience of Patients Newly Initiated on Pexidartinib for Tenosynovial Giant Cell Tumor

    Jun 1, 2024, 00:00

  • RWD43 The Use of Code Llama, a Large Language Model, as Programming Assistant in Real-World Research

    Jun 1, 2024, 00:00

  • EPH165 The Fiscal Costs of a Public Health Crisis: Lessons From Zika in the United States

    Jun 1, 2024, 00:00

  • CO77 A Systematic Literature Review of Real-World Treatment Effectiveness and Economic and Humanistic Burden in Patients with Muscle Invasive Bladder Cancer

    Jun 1, 2024, 00:00

  • PCR94 A Systematic Literature Review of Quality-of-Life Outcomes in Posttraumatic Stress Disorder (PTSD)

    Jun 1, 2024, 00:00

  • HSD111 Socio-Economic and Foeto-Maternal Characteristics of Home Childbirth in 12 African Countries: A Multinational Survey Using the Most Recent Demographic and Health Survey (DHS) Data

    Jun 1, 2024, 00:00

  • EE324 Describing the Clinical and Economic Burden of Women Diagnosed With Uterine Fibroid (UF) and Heavy Menstrual Bleeding (HMB) in a United States (US) Commercial Database 2015-2022

    Jun 1, 2024, 00:00

  • RWD4 A Real-World Data Landscape Review of the 2023 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Conference

    Jun 1, 2024, 00:00

  • HPR34 The Effect of Medical Insurance Outpatient Pooling Policy on Medical Service Utilization of Insured People: Evidence from CHARLS

    Jun 1, 2024, 00:00

  • EE240 Economic Impact of Direct Costs Associated with Stroke in Patients with Type 2 Diabetes from the Perspective of the Social Security and Private Healthcare Providers in Argentina

    Jun 1, 2024, 00:00

  • CO156 Indirect Treatment Comparison (ITC) of Cabotegravir Long Acting (CAB-LA) for Pre-Exposure Prophylaxis (PREP) Versus No Prep for HIV Prevention

    Jun 1, 2024, 00:00

  • PCR28 Baseline Characterization of Patient-Reported Disease Burden in a Virtual, Longitudinal Cohort of Myasthenia Gravis

    Jun 1, 2024, 00:00

  • EPH167 Real-World Treatment Patterns, Sequencing, and Unmet Need in Metastatic Colorectal Cancer (mCRC)

    Jun 1, 2024, 00:00

  • MSR50 Machine Learning Models for Predicting Metabolic Dysfunction-Associated Steatohepatitis (MASH) in the General United States Population

    Jun 1, 2024, 00:00

  • CO105 Disease Burden and Treatment in Patients with Essential Tremor in the United States: Real-World Evidence from a Cross-Sectional Survey of Physicians and Patients

    Jun 1, 2024, 00:00

  • HTA22 Assessing Cost-Savings From the Inflation Reduction Act in Louisiana Medicare Beneficiaries Due to Diabetes Medications

    Jun 1, 2024, 00:00

  • PCR247 Multidimensional Examination of Factors Determining Body Image Among Women of Reproductive Age in Hungary

    Jun 1, 2024, 00:00

  • HPR124 Is Obesity a Disease or a Lifestyle Issue in Europe and the United States? Payer Perception

    Jun 1, 2024, 00:00

  • EPH9 Safety Assessment of Nirmatrelvir-Ritonavir in the FDA Adverse Event Reporting System: A Data Mining Approach

    Jun 1, 2024, 00:00

  • EE31 The Annual Economic Burden of PFO-Related Cryptogenic Stroke in the U.S.: A Cost-of-Illness Study

    Jun 1, 2024, 00:00

  • PCR249 Understanding Caregiver Burden from Multiple Perspectives: Dyadic Agreement between Caregiver and Care Recipient

    Jun 1, 2024, 00:00

  • HPR82 Assessment of Supporting Evidence and Postmarketing Requirements for Therapeutic Indications With Real-Time Oncology Drug Review, 2018-2023

    Jun 1, 2024, 00:00

  • CO114 Clinical Characteristics, Diagnosis, and Impact on Employment in Patients With Obstructive Hypertrophic Cardiomyopathy: Results From a Real-World Survey in Canada

    Jun 1, 2024, 00:00

  • CO63 Real-World Comparative Effectiveness of the First COVID-19 mRNA Booster, mRNA-1273 Versus BNT162b2, Among US Medicare Fee-for-Service Non-Immunocompromised Beneficiaries Aged 65 and Older

    Jun 1, 2024, 00:00

  • Pricing and Regulatory Policies: Implications for Pharmaceutical Manufacturers

    Jun 1, 2024, 00:00

  • MSR33 Health State Transition Probabilities for Duchenne Muscular Dystrophy: Estimation from Published Data

    Jun 1, 2024, 00:00

  • EPH84 Relationship between the Effectiveness of Municipal Public Health Plans and Programs for the Prevention of Suicide and Suicide Attempts with Their Operational and Financial Performance

    Jun 1, 2024, 00:00

  • EE58 Quantifying the Lifetime Economic Impact of Pediatric Oral Nutritional Supplements in Lower-Middle Income Countries in Asia

    Jun 1, 2024, 00:00

  • PCR239 Perspectives on Pre-Exposure Prophylaxis (PrEP) Among People Who Could Benefit From PrEP: Qualitative Research Findings

    Jun 1, 2024, 00:00

  • HPR5 National US Health Equity Survey Demonstrates Some Progress on Organizational Health Equity Goals, Emerging Priorities on Activation, Analytics, and Capacity Building

    Jun 1, 2024, 00:00

  • PCR156 The Balancing Act of Paid Work and Caregiving in Duchenne Muscular Dystrophy (DMD): Results From a Cross-Sectional Survey

    Jun 1, 2024, 00:00

  • EE282 Cost-Equalization Approach to Estimate the Minimum Duration of Effect of Cell and Gene Therapies to Demonstrate Cost Savings to Payors: A Methodological Approach Using Late-Onset Pompe Disease

    Jun 1, 2024, 00:00

  • HSD70 Characteristics of Medicare Patients Initiating Long-Acting Injectable Antipsychotic Medications

    Jun 1, 2024, 00:00

  • EPH40 Changing Role of Comorbidities in Risk of Mortality Among Elderly Patients Diagnosed with COVID-19 in the United States: Examining Pre- and Post-Vaccine Clinical Risk Factors

    Jun 1, 2024, 00:00

  • PCR58 Subjective Expectations on Having Implanted Medical Devices at Older Ages: Results of a Cross-Sectional Population Survey

    Jun 1, 2024, 00:00

  • EPH14 Association between the Use of Macrolide Antibiotics and Recurrent Wheezing in Hospitalized Infants with Bronchiolitis

    Jun 1, 2024, 00:00

  • EE161 The Economic Burden of BRCA+ Metastatic Castration Resistant Prostate Cancer: Expert Perspective in LATAM Countries

    Jun 1, 2024, 00:00

  • Health Policy Regulatory

    Jun 1, 2024, 00:00

  • EE155 Budget Impact Analysis: Alteplase for Stroke Treatment in Argentina

    Jun 1, 2024, 00:00

  • CO96 Evidence Gap Analysis of the Burden of Illness and Treatment of Thyroid Eye Disease

    Jun 1, 2024, 00:00

  • EE91 Clinical Consequences and Associated Costs of Treating Patients With Chronic Lymphocytic Leukemia (CLL) With Bruton Tyrosine Kinase Inhibitors (BTKis) in the First-Line (1L) and Relapsed/Refractory (R/R) Settings

    Jun 1, 2024, 00:00

  • CO145 Incidence of Acute Exacerbations Among Patients With Fibrotic Interstitial Lung Disease in the United States

    Jun 1, 2024, 00:00

  • PCR253 Knowledge, Attitude, and Practices (KAP) Regarding Vaccination Against Human Papillomavirus (HPV) Among Young People, Caregivers, and Healthcare Professionals (HCPs)

    Jun 1, 2024, 00:00

  • HSD82 A Technology-Enabled Model to Define the Total Costs of Comprehensive Management of Hip and Knee Osteoarthritis: The Missing Link in Value Based Musculoskeletal Care

    Jun 1, 2024, 00:00

  • EE304 Healthcare Resource Utilization and Cost of Care of Different IV Iron Treatments in Heart Failure Patients Diagnosed With Iron Deficiency/Iron Deficiency Anemia Using a Real-World Database

    Jun 1, 2024, 00:00

  • CO182 Intelligence Quotient (IQ) Scores Among Early-Treated Phenylketonuria (PKU) Patients: Results from a Systematic Literature Review (SLR)

    Jun 1, 2024, 00:00

  • EPH231 HPV Genotyping in Invasive Cervical Cancer Samples from Women Attended at an Oncological Hospital between 2017-2021 in Ecuador

    Jun 1, 2024, 00:00

  • CO113 The Financial Effect of Closing the Hypertension Blood Pressure Care Gap at Blue Cross and Blue Shield of Louisiana

    Jun 1, 2024, 00:00

  • EE130 Economic Burden of Seasonal Influenza in Mainland China from 2011 to 2019

    Jun 1, 2024, 00:00

  • EE24 Analysis of out-of Pocket Payment Associated to Female Infertility in Hungary between 2015-2022

    Jun 1, 2024, 00:00

  • EE506 Clinical Consequences and Associated Costs of Treating Patients With Waldenström Macroglobulinemia in the First-Line Setting With Bruton Tyrosine Kinase Inhibitors

    Jun 1, 2024, 00:00

  • EPH51 Patient Characteristics and Treatment Patterns in Patients with Mantle Cell Lymphoma in China: A Real-World, Contemporary Cohort Study

    Jun 1, 2024, 00:00

  • PCR244 Prevalence of Plain-Language Summaries (PLS) in Open Access Patient-Reported Outcome (PRO) Publications

    Jun 1, 2024, 00:00

  • EE322 Addressing Decision Uncertainty in a Cost-Effectiveness Model of Opioid Use Disorder Treatments: Estimating the Value of Information and the Sample Size to Provide It

    Jun 1, 2024, 00:00

  • CO123 Socio-Demographics, Clinical Characteristics, and Quality of Life in Patients with Parkinson’s Disease with and without Comorbid Insomnia

    Jun 1, 2024, 00:00

  • EE135 Clinical and Economic Burden of Obesity in Low- and Middle-Income Countries: A Systematic Review

    Jun 1, 2024, 00:00

  • EE320 Budget Impact Analysis of TPMT and NUDT15 Pharmacogenomic Testing for 6-Mercaptopurine in Pediatric Acute Lymphocytic Leukemia Patients

    Jun 1, 2024, 00:00

  • EPH221 Stigma As a Barrier to Treatment: Evidence from the National Health and Wellness Survey

    Jun 1, 2024, 00:00

  • RWD107 Gender Disparities in the Management of Rheumatoid Arthritis in the US: A Real-World Evidence Study

    Jun 1, 2024, 00:00

  • HPR65 Assessing Rare Disease Reimbursement Levels and Economic Burden on Patients in China

    Jun 1, 2024, 00:00

  • HPR63 Research and Development (RD) Investment By the Biopharmaceutical Industry: A Global Ecosystem Update

    Jun 1, 2024, 00:00

  • CO125 Disease Burden of Epithelial Ovarian Cancer in Chinese Patients Under Current Care: A Model Simulation Study

    Jun 1, 2024, 00:00

  • MSR98 Prediction of Antipsychotic Associated Weight Gain in Children and Adolescents Taking Second Generation Antipsychotics: A Machine Learning Approach

    Jun 1, 2024, 00:00

  • P24 Real-World Impact of Treated Hereditary Angioedema Attacks on Patients’ Employment and Work Productivity

    Jun 1, 2024, 00:00

  • SA69 Enhancing the Value and Usefulness of Data Extracted From an Economic Systematic Literature Review

    Jun 1, 2024, 00:00

  • PCR104 The Self-Management Activities, Health Literacy and Health-Related Quality of Life of Patients with Type 2 Diabetes: A Structural Equation Modelling in Vietnam

    Jun 1, 2024, 00:00

  • EPH129 Tobacco Product Experien Which Consumer Reported Outcome Measures for Real World Evidence Studies?

    Jun 1, 2024, 00:00

  • PCR140 Psychometric Validation of the QOL-B Respiratory Domain in Adults with Newly Diagnosed or Recurrent Mycobacterium avium Complex (MAC) Lung Disease: The ARISE and ENCORE Studies

    Jun 1, 2024, 00:00

  • HPR24 Understanding Pharmacy Benefit Manager (PBM) Adoption of Humira Biosimilars and Identifying Their Preferred Humira Biosimilars in Comparison with Humira

    Jun 1, 2024, 00:00

  • P43 Cost-Effectiveness of Talquetamab-tgvs Vs Idecabtagene Vicleucel for Triple-Class Exposed Relapsed or Refractory Multiple Myeloma

    Jun 1, 2024, 00:00

  • EE478 Willingness to Pay Study for Migraine Medications in Argentina

    Jun 1, 2024, 00:00

  • HTA24 Adopting a Societal Perspective in Health-Economic Evaluation: A Review of 9 HTA Methodological Guidelines on How to Integrate Societal Costs

    Jun 1, 2024, 00:00

  • CO157 Characteristics of Medicare Beneficiaries With Multiple Administrations of CAR-T Therapy

    Jun 1, 2024, 00:00

  • EE139 Intensification with Insulin Glargine 300 U/Ml (Gla-300) or First- Generation Basal Insulins (BIs) in People with Type 2 Diabetes (T2D) on Once-Weekly Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs): Deliver New-G

    Jun 1, 2024, 00:00

  • OP1 Assessing the Quality and Impact of Patient Engagement: Co-Creation of the Patient Engagement Impact Measurement (PEIM) Framework and Metrics

    Jun 1, 2024, 00:00

  • EPH121 Prevalence and Correlates of Alcohol Use Disorder Diagnosis Among Cancer Survivors in the United States: Insights From a Real-World Study

    Jun 1, 2024, 00:00

  • CO181 Upadacitinib in Moderate-to-Severe Crohn's Disease (CD): A Systematic Review of Remission Outcomes in Adults With Inadequate Response or Intolerance to Biologic Drugs

    Jun 1, 2024, 00:00

  • MSR69 Systematic Review and Meta-Analysis of Fecal Incontinence Prevalence and Population Estimates

    Jun 1, 2024, 00:00

  • EPH64 Assessing the Relationship Between Pain Intensity and Health Status Among Older US Adult Opioid Users With Pain

    Jun 1, 2024, 00:00

  • EE527 Is List Price the Key Driver of ICER Assessments? Exploring Drivers of Cost-Effectiveness

    Jun 1, 2024, 00:00

  • RWD91 Healthcare Resource Utilization and Costs Associated with COVID-19 in Colombia: A Retrospective Database Study

    Jun 1, 2024, 00:00

  • EE507 Frontline TKI Strategies for Chronic Myeloid Leukemia Patients: Balancing Outcomes and Costs in Pursuit of Treatment-Free Remission and Dose Reduction

    Jun 1, 2024, 00:00

  • RWD126 Evaluation of the Importance of One-Day Surgical Treatment in Benign Gynecological Surgeries

    Jun 1, 2024, 00:00

  • SA42 Cognitive Impairment and Cardiovascular Disease in Older Adults: An Evaluation Using Pooled Observational Data

    Jun 1, 2024, 00:00

  • RWD169 Prevalence of ANCA-Associated Vasculitis in Adults in Colombia: A Real-World Data Analysis

    Jun 1, 2024, 00:00

  • HPR4 What Makes an Orphan Medicine? Determining Characteristics of Non-Oncology Orphan Approvals from 2015-2022

    Jun 1, 2024, 00:00

  • HTA32 Augmenting Health Economic Evidence Analysis: The Synergistic Role of AI in Deductive, Abductive Reasoning, and Insight Generation

    Jun 1, 2024, 00:00

  • EE81 Cost-Effectiveness Analysis of Pegmolesatide Compared to Darbepoetin in Patients With Anemia Caused by Chronic Kidney Disease: The Case of China

    Jun 1, 2024, 00:00

  • RWD84 Changes in the Number of Hysterectomy Performed in Europe between 2010-2021

    Jun 1, 2024, 00:00

  • P12 Racial and Ethnic Fairness in Risk Prediction Models for Cardiovascular Diseases Among U.S. Adults

    Jun 1, 2024, 00:00

  • MSR101 A Novel Methodology for Assessing Response to Lymphoma Treatment in Real-World Studies – the Real-World Lugano (RWLUGANO) Study

    Jun 1, 2024, 00:00

  • PCR11 The Impact and Burden of Visual Impairment in Patients With Dry Age-Related Macular Degeneration Relative to Older Adults Without Major Eye Conditions: A Qualitative Interview Study

    Jun 1, 2024, 00:00

  • EE433 Why Economic Methods for Discounting Are Wrong, What Are the Consequences, and How to Fix It

    Jun 1, 2024, 00:00

  • CO39 Influence of Socioeconomic Status on Breast Cancer Treatment in the US: Preliminary Results from a Systematic Literature Review

    Jun 1, 2024, 00:00

  • EE441 Cost-Effectiveness of a Comprehensive Team-Based Intervention for Pregnant Women with Diabetes: A Markov Cohort Study

    Jun 1, 2024, 00:00

  • P14 Health Equity Impacts of Alteplase for Ischemic Stroke in the United States: A Distributional Cost-Effectiveness Analysis

    Jun 1, 2024, 00:00

  • PCR85 Are There Differences in the Sociodemographic Characteristics of Total Hip Arthroplasty Patients in Public and Private Health Care?

    Jun 1, 2024, 00:00

  • HPR25 Current Reimbursement Landscape for Re-Treatment with Anti-PD-(L)1 Agents after Treatment in Early-Stage Cancers: A Payer Survey

    Jun 1, 2024, 00:00

  • EPH43 Systematic Review of Real-World Data: Assessing Cancer, Major Adverse Cardiovascular Events, Venous Thromboembolism, Infection, and Mortality Risk Associated With Jak Inhibitors in Rheumatoid Arthritis Patients in the United States

    Jun 1, 2024, 00:00

  • HSD18 Patients' Perceptions of Safety of the Health Care in a Large Hospital Institution in Barranquilla, Colombia

    Jun 1, 2024, 00:00

  • EE105 Cost-Effectiveness Analysis of Linperlisib for Relapsed or Refractory Follicular Lymphoma Based on Matching Adjusted Indirect Comparison in China

    Jun 1, 2024, 00:00

  • OP2 Health Insurance Cost Management: Perspective from the Caribbean Region, Colombia

    Jun 1, 2024, 00:00

  • RWD88 Exploring Patient Characteristics and Treatment in Real-World Endometrial Cancer Patients Users of Platinum Therapy

    Jun 1, 2024, 00:00

  • HSD126 Diagnosing Rare Diseases: Referral Behaviors of Physicians in the United States

    Jun 1, 2024, 00:00

  • SA6 Balancing Feasibility, Time, and Comprehensiveness: Approaches to Rapid Reviews of Health Economic Models

    Jun 1, 2024, 00:00

  • Health Policy Regulatory

    Jun 1, 2024, 00:00

  • CO188 Fit-for-Purpose and Scalable Strategy to Address Mortality Completeness for Oncology Research: Comparison of Multiple Real-World Sources with the National Death Index

    Jun 1, 2024, 00:00

  • Critical Comments by Food and Drug Administration Reviewers on Patient-Reported Outcomes in Food and Drug Administration Regulatory Submissions (2018-2021) [Editor's Choice]

    Jun 1, 2024, 00:00

  • EE36 Comparison of Healthcare Resource Utilization and Costs in Patients With Venous Thromboembolism Receiving Direct-Acting Oral Anticoagulants or Low Molecular Weight Heparins: A Real-World Data Analysis

    Jun 1, 2024, 00:00

  • EPH211 Treatment Patterns and Clinical Characteristics of Patients Diagnosed with Metastatic NSCLC in Hmo from Colombia: A Real Word Evidence Study

    Jun 1, 2024, 00:00

  • EPH34 Changes in the Epidemiological Burden of Breast Neoplasms in Colombia After the Cancer Control Model

    Jun 1, 2024, 00:00

  • EE259 Care-Seeking Pattern and Costs of Health Services in Individuals with Multiple Chronic Conditions

    Jun 1, 2024, 00:00

  • EPH229 Inequalities According to Health Regime, in the Survival of Colorectal Cancer in a Colombian Caribbean City

    Jun 1, 2024, 00:00

  • MSR5 Leveraging Machine Learning To Understand Pet Owner Experiences of Feline Pruritus Through Social Media Listening

    Jun 1, 2024, 00:00

  • EE253 An Evaluation of the Prevalence of Diagnosed Opioid Use Disorder and the Economic Burden of Opioid Use Disorder–Related Healthcare Costs in the United States

    Jun 1, 2024, 00:00

  • OP20 Objective Measurement of Quality of Life: First Results of the Project "Machine Intelligence for the Objective Determination of Individual Quality of Life" - MI-Lq

    Jun 1, 2024, 00:00

  • HPR98 Consumption of Hospital Resources in Intensive Care Units in Brazil: A Challenge for Health Financing

    Jun 1, 2024, 00:00

  • RWD28 Adherence to Janus Kinase Inhibitors Among Older Adults with Rheumatoid Arthritis Initiating New Treatment

    Jun 1, 2024, 00:00

  • HPR140 Are North Americans Willing-to-Pay More for Life and Limb?

    Jun 1, 2024, 00:00

  • EPH61 Timing of SGLT2 Inhibitor Initiation and Hospital Readmission in Acute Heart Failure With Type 2 Diabetes: A Target Trial Emulation Cohort Study

    Jun 1, 2024, 00:00

  • EPH164 Results and Impact of the Acceleration Plan Implementation for Maternal Mortality Reduction in the Department of Bolívar, Colombia

    Jun 1, 2024, 00:00

  • CO127 Newer Glucose-Lowering Drugs and Risk of Suicide: A Network Meta-Analysis of Randomized Outcome Trials

    Jun 1, 2024, 00:00

  • EPH32 Behaviors and Characteristics of Current and Previous Users of Glucagon-like Peptide-1 Receptor Agonists (GLP-1) in an Online Health Community

    Jun 1, 2024, 00:00

  • P50 Increasingly Stringent Clinical Responses and the Association with Improvements in Pain, HRQoL, and Work Productivity in Patients with Hidradenitis Suppurativa: 16-Week Results from Phase 3 Studies BE HEARD III

    Jun 1, 2024, 00:00

  • HPR153 Improving Prediction of Medical Costs Among Medicare Beneficiaries By Incorporating Social Determinants of Health Indicators in Risk Prediction

    Jun 1, 2024, 00:00

  • MSR30 Use of Natural Language Processing to Augment Real-World Data (RWD) and Identify Eligible Patients at Scale for Oncology Studies

    Jun 1, 2024, 00:00

  • SA47 A Systematic Literature Review and Pooled Rates Analysis of Heart Failure Trials in the US

    Jun 1, 2024, 00:00

  • EE492 Cost-Effectiveness Analysis of the Use of Negative Pressure Wound Therapy in the Treatment of Diabetic Foot Disease in Colombia

    Jun 1, 2024, 00:00

  • PCR181 Predicting COVID-19 Vaccine Hesitancy through Integrated Protection Motivation Theory Constructs

    Jun 1, 2024, 00:00

  • Study Approaches

    Jun 1, 2024, 00:00

  • HTA55 USA Vs. Global Pharmaceutical Launches: What Are the Potential Reasons That Can Result in a Pharmaceutical Not Being Commercialized Outside the USA?

    Jun 1, 2024, 00:00

  • HSD34 Analysis of Changes in the Number of Cases of Gynecological Surgeries for Benign Indications in Hungary

    Jun 1, 2024, 00:00

  • PCR101 Characterizing the Experience of Caregiving for Those With Duchenne Muscular Dystrophy (DMD): Results From a Cross-Sectional Survey

    Jun 1, 2024, 00:00

  • PCR30 An Investigation of Patient Journey Assessment in Rare Disease

    Jun 1, 2024, 00:00

  • HTA80 Impact of Restricted EU Market Access Decisions on Patient Access To Medicines in Multiple Myeloma

    Jun 1, 2024, 00:00

  • PCR134 Psychometric Properties of the Multiple Myeloma Symptom and Impact Questionnaire (MySIm-Q) in Patients with Relapsed/Refractory Multiple Myeloma (MM): Analysis of Phase 2 CARTITUDE-2 Study Cohorts A, B, and C

    Jun 1, 2024, 00:00

  • PCR266 Patient Preferences for Continuous Glucose Monitoring Devices: A Preliminary Study from People Living with Type 2 Diabetes

    Jun 1, 2024, 00:00

  • PCR234 Patient and Oncologist Preferences for Anaplastic Lymphoma Kinase Positive Advanced Non-Small Cell Lung Cancer (ALK+ aNSCLC) Tyrosine Kinase Inhibitors (TKIs) Treatments in the First Line (1L) Setting

    Jun 1, 2024, 00:00

  • EE69 Estimating a Drug's Price After Loss of Exclusivity As a Function of the Cost of Goods Sold

    Jun 1, 2024, 00:00

  • RWD155 Real-World Treatment Patterns Among Adult Patients with Advanced Non-Small Cell Lung Cancer in the US

    Jun 1, 2024, 00:00

  • RWD41 Adherence Trajectories in Medicaid Drug-Naïve Type 2 Diabetes Patients: A Comparative Study between Initial Combination Therapy and Step-Therapy Approaches

    Jun 1, 2024, 00:00

  • CO165 Changes in Mortality Rates With the Introduction of Immuno-Oncology Therapy in Advanced Non-Small Cell Lung Cancer: A Seer-Medicare Analysis

    Jun 1, 2024, 00:00

  • CO167 Type of Pre-Existing Chronic Conditions and Their Associations with Merkel Cell Carcinoma Treatment: Prediction and Interpretation Using Machine Learning Methods

    Jun 1, 2024, 00:00

  • EE56 Bearing the Brunt: Disproportionate Burden Among Female Parent-Caregivers in Rare Disease

    Jun 1, 2024, 00:00

  • EPH77 Identifying the Characteristics of Tramadol Usage Among West Virginians

    Jun 1, 2024, 00:00

  • EE519 Economic Evaluations of Digital Health Interventions: Is Existing Guidance Being Used?

    Jun 1, 2024, 00:00

  • EPH16 Changes in Neutropenia Outcomes Following Implementation of the Clozapine Risk Evaluation and Mitigation Strategy Update

    Jun 1, 2024, 00:00

  • PCR138 Physiotherapy of Knee Osteoarthritis with Mechanical Traction in a Nuremberg Suspension Grid

    Jun 1, 2024, 00:00

  • PCR252 Assessing Treatment Preference in Pediatric Growth Hormone Deficiency: Challenges and Proposed Solutions

    Jun 1, 2024, 00:00

  • PCR84 Urinary Incontinence and Pelvic Organ Prolapse Knowledge Among Young Women Living in Hungary

    Jun 1, 2024, 00:00

  • CO30 Comparative Genitourinary Safety of in-Class Sodium Glucose Co-Transporter-2 Inhibitors Among Patients with Heart Failure with Preserved Ejection Fraction

    Jun 1, 2024, 00:00

  • HTA1 Stakeholders Perspectives About Patient Participation in HTA in Latin America: Best Practices, Main Gaps, and Recommendations

    Jun 1, 2024, 00:00

  • PCR87 Supporting Diversity and Inclusion Through the Evaluation of Differential Item Functioning (DIF) By Race and Ethnicity in the Asthma Control Questionnaire and Asthma Quality of Life Questionnaire Using Dupilumab Phase 3 Data

    Jun 1, 2024, 00:00

  • EE471 Budget Impact of Pirtobrutinib for Patients With Mantle Cell Lymphoma (MCL) or Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in the United States (US)

    Jun 1, 2024, 00:00

  • EE497 The Cost-Effectiveness of Semaglutide 2.4MG in Patients With Overweight/Obesity and Cardiovascular Disease From the Select Trial

    Jun 1, 2024, 00:00

  • PCR206 Comparison of the Measurement Properties of EQ-5D-Y-3L and CHU-9D Among Chinese High School Students with Myopia

    Jun 1, 2024, 00:00

  • SA76 A Targeted Literature Review of Economic Evaluations, Health-Related Quality of Life, Healthcare Resource Use, and Costs Associated With Polymyalgia Rheumatica

    Jun 1, 2024, 00:00

  • RWD81 Economic Impact of Epilepsy in Private Healthcare in Brazil

    Jun 1, 2024, 00:00

  • HPR2 The Use of Performance-Based Agreements in Common Diseases in EU3 and US

    Jun 1, 2024, 00:00

  • HTA31 Analyzing Indirect Treatment Comparisons in Eunethta Assessments: Lessons Learned for the Implementation of EU Joint Clinical Assessments?

    Jun 1, 2024, 00:00

  • RWD49 Real-World Impact of Erenumab on Adherence, Work Absenteeism, and Rescue Medication Utilization Among Patients With Migraine: Results of an Outcomes-Based Agreement

    Jun 1, 2024, 00:00

  • CO65 Overall Survival in Metastatic NSCLC in HMO From Colombia: A Non-Interventional Study

    Jun 1, 2024, 00:00

  • PCR57 The Dara Project: Assessing Health and Well-Being Measures in Economically Disadvantaged Families

    Jun 1, 2024, 00:00

  • MSR104 Use of Stochastic Search Variable Selection for Dimension Reduction in Large NMAs

    Jun 1, 2024, 00:00

  • EE45 Influential Factors on the Economic Justifiable Pri Systematic Investigation of Factors and Mechanisms Beyond the Incremental Cost Effectiveness Ratio

    Jun 1, 2024, 00:00

  • EE408 Healthcare Costs Among Patients Diagnosed With Estrogen Receptor Positive (ER+) Breast Cancer: Relationship With Comorbid Depression and Adherence to Anti-Depressant Medication

    Jun 1, 2024, 00:00

  • HTA62 Understanding the Disconnect: Characterizing Trends in Inclusion of Family and Informal Caregiver Spillover in US Value Assessments

    Jun 1, 2024, 00:00

  • EE267 Budget Impact Analysis of Introducing Fruquintinib for the Treatment of Previously Treated Metastatic Colorectal Cancer in the United States From the Payer Perspective

    Jun 1, 2024, 00:00

  • SA53 Does Mode Matter? Impact of Survey Administration Mode on Health-Related Contingent Valuation: Face-to-Face and Telephone Interviews

    Jun 1, 2024, 00:00

  • EE281 Cost-Effectiveness of Every Two Month Cabotegravir Long-Acting (CAB-LA) for Pre-Exposure Prophylaxis (PREP) Compared with Daily Oral Tenofovir Disoproxil Fumarate (TDF)/ Emtricitabine (FTC) As Prep to Prevent HIV-1 in the UK

    Jun 1, 2024, 00:00

  • EE388 Economic Evaluation and Budget Impact of Brigatinib Versus Other ALK-Inhibitors for First-Line ALK-Positive Non-Small Cell Lung Cancer (NSCLC) Treatment in the Brazilian Private Healthcare System

    Jun 1, 2024, 00:00

  • RWD119 A Methodological Approach Using Sentiment Analysis of Online Medical Platforms As a Real-World Data Source of Patient Experiences

    Jun 1, 2024, 00:00

  • PCR32 Comparison of Quality of Life Based on Sociodemographic and Surgical Data Among Total Hip Arthroplasty Patients in Hungary

    Jun 1, 2024, 00:00

  • PCR214 Patients’ Preference and the Influencing Factors of Treatment Compliance in Chinese Patients With Maculopathy: A Qualitative Interview Research

    Jun 1, 2024, 00:00

  • SA65 Healthcare Resource Utilization Following 6 Months of Treatment With Olanzapine/Samidorphan: Real-World Assessment of Patients With Schizophrenia or Bipolar I Disorder

    Jun 1, 2024, 00:00

  • EE484 Clinical and Healthcare Resource Burden of Disease in Patients With Lennox-Gastaut Syndrome (LGS): Results From a US Claims Matched-Control Analysis

    Jun 1, 2024, 00:00

  • P20 Cardioprotective Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors in Early Breast Cancer Following Anthracycline- or Trastuzumab-Based Chemotherapy

    Jun 1, 2024, 00:00

  • EE269 Direct Medical Costs in Patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC) in Colombia

    Jun 1, 2024, 00:00

  • PCR93 Assessment of Prior Experience With Pharmacists and Perceptions of Pharmacists’ Education and Training on Metabolic Syndrome (MetS) Patients’ Willingness to Accept Pharmacist-Provided Services

    Jun 1, 2024, 00:00

  • HSD49 U.S. Real-World Biosimilar Adoption By Specialty Therapeutic Area

    Jun 1, 2024, 00:00

  • MSR23 Optimizing Regression Models for Patient-Level Utility Scores: A Case Study on Addressing Ceiling Effects in EQ-5D Data from the MYR301 Clinical Trial

    Jun 1, 2024, 00:00

  • EE47 Cost Per Recurrence-Free Survivor (CPRS) and Cost Per Recurrence-Free Life Month (CPRLM) of Adjuvant Nivolumab (NIVO) Versus Pembrolizumab (PEMBRO) Among Patients With Resected Stage IIB/IIC Melanoma

    Jun 1, 2024, 00:00

  • EE344 Expected Economic Savings Associated With Surgical Aortic Valve Replacement Using a Novel Tissue Bioprosthesis: An Update Based on the 7-Year Commence Trial Results

    Jun 1, 2024, 00:00

  • EE173 Exploring the Financial Burden Associated with the Management of Dystrophic Epidermolysis Bullosa (DEB): A Systematic Literature Review (SLR) with Database Review of Future Disease-Modifying Therapies (DMTs)

    Jun 1, 2024, 00:00

  • EE41 Economic Evaluation for the United States (US) of the Overall Survival Analysis of Cemiplimab Plus Chemotherapy Treatment in Advanced Non-Small Cell Lung Cancer (NSCLC) With at Least 50% PD-L1 Positivity

    Jun 1, 2024, 00:00

  • EPH72 Mortality From Diabetes Mellitus in the Department of Bolívar, Colombia: A 5-Year Analysis

    Jun 1, 2024, 00:00

  • EPH131 Adolescent Pregnancy Before and During the SARS Cov-2 Pandemic in Cartagena De Indias, Colombia 2015 - 2021

    Jun 1, 2024, 00:00

  • EE460 Theoretical Exploration of the Inclusion of Non-Traditional Multiple Sclerosis Measurement Variables on the Cost-Effectiveness of Future Treatments

    Jun 1, 2024, 00:00

  • HPR73 Breast Cancer-Related Healthcare Resource Utilization and Staging before and after the COVID-19 Pandemic Among White and Black Patients with Newly Diagnosed Breast Cancer

    Jun 1, 2024, 00:00

  • CO55 Incidence of Adverse Events with Pembrolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Systematic Review of Literature

    Jun 1, 2024, 00:00

  • Real-World Data Information Systems

    Jun 1, 2024, 00:00

  • HPR126 Monitoring Drug Volume-Based Procurement in Shanghai, China: A Data-Driven Situation Analysis

    Jun 1, 2024, 00:00

  • RWD179 Resource Utilization and Direct Costs of Diabetes in Relation to Heart Failure Status in Private Payer Perspective in Brazil

    Jun 1, 2024, 00:00

  • EE156 Temporal Excess Hospital Costs of Complications in Chinese Patients With Type 2 Diabetes: Results from the Joint Asia Diabetes Evaluation (JADE) Register (2007-2018)

    Jun 1, 2024, 00:00

  • EE412 Real-World Cost-Effectiveness Analysis of Ustekinumab-Based Therapies Vs Non-Biologic Therapies for Moderate to Severe Crohn’s Disease in Chinese Population

    Jun 1, 2024, 00:00

  • MSR89 Machine Learning-Based Approach to Discover Subtypes of Light-Chain Amyloidosis Using US Claims Data

    Jun 1, 2024, 00:00

  • Disclaimer

    Jun 1, 2024, 00:00

  • Psychometric Evaluation of the Patient’s Knee Implant Performance Questionnaire

    Jun 1, 2024, 00:00

  • SA30 Symptom Burden and Healthcare Resource Use in Claudin 18.2+ (CLDN18.2+), HER2− Patients With Locally Advanced (LA) Unresectable or Metastatic Gastric or Gastroesophageal Junction (mG/GEJ) Adenocarcinoma

    Jun 1, 2024, 00:00

  • PCR106 Willingness To Pay for Temporary Alleviation of Anemia Status Transfusion-Dependent Beta-Thalassemia Patients in China

    Jun 1, 2024, 00:00

  • EPH175 Assessment of Streptococcus Pneumoniae as Cause of Acute Otitis Media in Young Children in Colombia: A Prospective Study

    Jun 1, 2024, 00:00

  • EE417 Healthcare Resource Use and Costs of Care in HR+/HER2- Metastatic Breast Cancer: A Retrospective US Claims Data Study

    Jun 1, 2024, 00:00

  • EPH4 Assessing the Association Between Body Mass Index, Cholesterol, and Cancer Among United States Adults in the Medical Expenditure Panel Survey Using a Cross-Sectional Design

    Jun 1, 2024, 00:00

  • PCR152 Can We Speak to GPT to Inform Patient Preference Studies?

    Jun 1, 2024, 00:00

  • PCR170 Mental Health Status, Symptoms and Sleep Quality of Patients Hospitalized for Infection with COVID-19

    Jun 1, 2024, 00:00

  • The Patient and Caregiver Perspective for Healthcare Decision-Making

    Jun 1, 2024, 00:00

  • Healthcare Resource Utilization and Cost Burden of Selected Chronic Conditions

    Jun 1, 2024, 00:00

  • HTA42 Vignette-Based Estimation of Utilities in Patients with Metastatic Breast Cancer in Japan

    Jun 1, 2024, 00:00

  • P34 National Costs of Prescription Drug Market Exclusivity Extensions

    Jun 1, 2024, 00:00

  • RWD143 Update of Our Review of Real-World Evidence in HTA Decision-Making of Gene Therapies in the US, Canada, UK, EU4, and Japan

    Jun 1, 2024, 00:00

  • HTA35 Selection of Appropriate Endpoints for the EU JCA and National Assessments in Select Member States and England for ATMPs

    Jun 1, 2024, 00:00

  • SA13 Approaches to Electronic Health Records Notes Selection: Considerations for Best Practices

    Jun 1, 2024, 00:00

  • Author Reply

    Jun 1, 2024, 00:00

  • HPR149 Americans' Views on Health Inequality in the United States: Results from a General Population Survey

    Jun 1, 2024, 00:00

  • MT46 Patient Experience and Outcomes with Post-Surgical Remote Monitoring for Patients with Total Knee Arthroplasty (TKA)

    Jun 1, 2024, 00:00

  • EE416 Cost-Effectiveness of Sulbactam-Durlobactam Compared to Colistin in Treating Carbapenem-Resistant Acinetobacter Baumannii Infections in Critical Care Setting in the United States: A Decision Analysis

    Jun 1, 2024, 00:00

  • HTA41 Analysis of Intensity of Use of Real-World Data in Single Technology Appraisals of Cancer Drugs By the National Institute for Health and Care Excellence

    Jun 1, 2024, 00:00

  • MSR17 Leveraging Large Language Models (LLMs) for Classifying Peer Reviewed Publications for Literature Review

    Jun 1, 2024, 00:00

  • PT23 Is a Large Language Model (LLM) More Accurate Than Human Researchers in Correctly Identifying Diseases in Biomedical Abstracts? A Pilot Study

    Jun 1, 2024, 00:00

  • HSD119 Unveiling Priority Challenges in the Healthcare System for Ovarian Cancer: Advancement and Plausible Solutions

    Jun 1, 2024, 00:00

  • EE122 Analyses of Cancer Prevalence and Healthcare Costs for Metastatic and Non-Metastatic Cancers Among Employees Using Claims Data

    Jun 1, 2024, 00:00

  • CO118 Sickle Cell Disease Outcomes in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Literature Review

    Jun 1, 2024, 00:00

  • RWD89 Healthcare Resource Utilization and Health-Related Quality of Life in Patients With Resectable Non-Metastatic Non-Small Cell Lung Cancer Treated With Neoadjuvant Chemotherapy in China: A Real-World Survey

    Jun 1, 2024, 00:00

  • PCR231 Changes in Health-Related Quality of Life in Vivax Malaria Patients: Measurement and Valuation in Indonesia and Cambodia

    Jun 1, 2024, 00:00

  • Assessing the Performance of Alternative Methods for Estimating Long-Term Survival Benefit of Immuno-oncology Therapies

    Jun 1, 2024, 00:00

  • PCR229 Development of the ADHD Treatment Satisfaction Questionnaire (ATSQ) for Use with Children, Adolescents, and Their Caregivers

    Jun 1, 2024, 00:00

  • RWD138 Evidence Gap Analysis of the Burden of Illness and Treatment of Myasthenia Gravis

    Jun 1, 2024, 00:00

  • EE238 The Budget Impact of Establishing a County-Level Cancer Prevention and Care Center in China

    Jun 1, 2024, 00:00

  • PCR191 Patient-Centric Assessment of Treatment Experience in Breast Cancer: Development and Validation of a Patient Questionnaire

    Jun 1, 2024, 00:00

  • EE355 Can Large Language Models Generate Conceptual Health Economic Models?

    Jun 1, 2024, 00:00

  • RWD31 Racial Disparities in Hepatocellular Carcinoma Recurrence After Liver Transplant in US: A Real-World Data Study

    Jun 1, 2024, 00:00

  • EE406 Economic Impact of Upadacitinib for the Treatment of Moderate-to-Severe Crohn’s Disease and Ulcerative Colitis: Induction and Maintenance Phase 3 Results on Work Productivity Loss

    Jun 1, 2024, 00:00

  • RWD12 Potentially Modifiable Risk Factors for Alzheimer Disease in Colombia: A Real-World Data Analysis

    Jun 1, 2024, 00:00

  • EE392 Number Needed to Treat (NNT) Comparing Sacituzumab Govitecan and Single-Agent Chemotherapy in Relapsed or Refractory Metastatic Triple-Negative Breast Cancer

    Jun 1, 2024, 00:00

  • PCR240 Medication Adherence to Direct Acting Anti-Viral Agents Among Hepatitis C Virus Infected Patients in the United States

    Jun 1, 2024, 00:00

  • CO130 Diagnosis, Treatment, and Control of Hypertension Among US Adults: The National Health and Nutrition Examination Survey, 2009 to 2020

    Jun 1, 2024, 00:00

  • MT29 Budget-Impact of Implementing an Outpatient Heart Failure Management System Following Diagnosis of Heart Failure

    Jun 1, 2024, 00:00

  • RWD77 Time to Reimbursement in Kazakhstan for Novel Biologic Medicines Approved during the Period 2013-2022

    Jun 1, 2024, 00:00

  • CO129 Novel Endpoints in Chronic Kidney Disease (CKD): Trends in the Use of eGFR Slope and Proteinuria As Efficacy Endpoints in Clinical Trials

    Jun 1, 2024, 00:00

  • HPR99 Medicare Drug Price Negotiation: The Complexities of Selecting Therapeutic Alternatives for Estimating Comparative Effectiveness

    Jun 1, 2024, 00:00

  • RWD124 Validation of Treatment Patterns in Adults With Chronic Inflammatory Demyelinating Polyneuropathy in the United States Using Administrative Claims Datasets

    Jun 1, 2024, 00:00

  • EE172 Quantifying the Relationship between Time to Diagnosis and Potential System Level Burden in Obstructive Hypertrophic Cardiomyopathy (HCM)

    Jun 1, 2024, 00:00

  • P16 Generalized Prevalence-Adjusted Willingness-to-Pay to Control for Health Equity in Cost-Effectiveness Analysis

    Jun 1, 2024, 00:00

  • EPH101 Estimating Total Number of Influenza Cases From Reported Hospitalizations: A Multi-Country Comparison of the Multiplier Method

    Jun 1, 2024, 00:00

  • MSR51 Evaluation of Machine Learning Approaches in Predicting the Initial Treatment Strategy in Patients with Multiple Sclerosis

    Jun 1, 2024, 00:00

  • HSD35 Real-World Treatment Patterns and Treatment Sequences in the Metastatic Castration-Resistant Prostate Cancer Settings across Europe

    Jun 1, 2024, 00:00

  • SA34 Cost-Effectiveness Analysis of the Use of Negative Pressure Wound Therapy in the Treatment of Diabetic Foot Disease - A Systematic Literature Review

    Jun 1, 2024, 00:00

  • CO20 Treatment Regimens and Persistence in Colombian Patients Diagnosed With Rheumatologic Diseases After Failure of Conventional Disease-Modifying Antirheumatic Drugs

    Jun 1, 2024, 00:00

  • RWD141 Assessing the Potential Value of the Flatiron Health Commercial Mortality Data Combined with Publicly Available Death Data for Non-Oncology Research

    Jun 1, 2024, 00:00

  • EPH184 Patient Journey of Head Neck Squamous Cell Cancer in Oncology Centers in Colombia

    Jun 1, 2024, 00:00

  • EPH217 Annual Epidemiological and Health Insurance Disease Burden of Endometriosis in Hungary Based on Real-World Health Insurance Claims Data

    Jun 1, 2024, 00:00

  • PCR125 Measuring and Valuing Health for Children: A Series of Reviews to Inform Health Technology Assessment

    Jun 1, 2024, 00:00

  • SA56 Disease Severity Is Associated With Poorer Quality of Life Outcomes and Higher Costs in Thyroid Eye Disease (TED): Evidence From Systematic Literature Reviews (SLRs)

    Jun 1, 2024, 00:00

  • EPH202 Assessing Trends in Utilization and Off-Label Prescribing for Ozempic, a Glucagon-like Peptide Receptor Agonist

    Jun 1, 2024, 00:00

  • MSR81 Quantitative Assessment of Effect Modifiers in NMA - Leveraging Subgroup Data

    Jun 1, 2024, 00:00

  • HPR20 Comparison of Biosimilar Reimbursement Policies in the US and Select European Markets

    Jun 1, 2024, 00:00

  • EPH197 Characterization of Adult Patients With Primary Chronic Immune Thrombocytopenia Using US Administrative Claims Data

    Jun 1, 2024, 00:00

  • HTA57 Uptake of Early Health Technology Assessment in the United States (US): A Literature Review of Empirical Studies

    Jun 1, 2024, 00:00

  • Multidimensional Thresholding for Individual-Level Preference Elicitation

    Jun 1, 2024, 00:00

  • HPR93 Price Evolution of Selected Cancer Immunotherapies in the US and Key European Markets

    Jun 1, 2024, 00:00

  • EPH88 Pregnancy and Perinatal Outcomes Following Exposure to Medications for Opioid Use Disorder: An Analysis of FAERS (FDA Adverse Event Reporting System)

    Jun 1, 2024, 00:00

  • CO53 Real-World Evidence of the Effectiveness of Inhaled Corticosteroid-Containing Therapies in Reducing Exacerbations and Medical Costs in COPD

    Jun 1, 2024, 00:00

  • EPH191 Age-Related Trends of Blood Glucose, Hyperglycemia, and Type 2 Diabetes in Youth Prescribed Second-Generation Antipsychotic Medications

    Jun 1, 2024, 00:00

  • HTA16 A Preliminary Assessment of ICER's New HTA Methods That Support Health Equity

    Jun 1, 2024, 00:00

  • EE104 Value Assessment of Emerging Treatments for Nonalcoholic Steatohepatitis: Lessons from Institute for Clinical and Economic Review Evaluations

    Jun 1, 2024, 00:00

  • HSD29 Predicting Psoriasis Area and Severity Index From Physician Global Assessment and Body Surface Area in the Real-World Dermatology Setting

    Jun 1, 2024, 00:00

  • EPH177 Clinical and Sociodemographic Characteristics of Patients With Vitiligo in Colombia: Preliminary Results From REVIC

    Jun 1, 2024, 00:00

  • MT40 Budget Impact of Implementing an Advanced Interventional Suite Platform for Interventional Procedures

    Jun 1, 2024, 00:00

  • PT10 Utility of the ISPOR Presentations Database to Support the Centers for Medicare and Medicaid Services (CMS) Drug Price Negotiation (DPN): An Apixaban and Rivaroxaban Case Study

    Jun 1, 2024, 00:00

  • P6 The Effect of Formulary Restrictions on the Disease Outcomes Among Medicare Beneficiaries With Multiple Sclerosis in the United States

    Jun 1, 2024, 00:00

  • CO10 Early Adoption and Utilization of Perfluorohexyloctane for Treatment of Dry Eye Disease

    Jun 1, 2024, 00:00

  • EE476 Cost of COVID-19 Vaccine Delivery Integration into Routine Immunization and Service Delivery in South Africa

    Jun 1, 2024, 00:00

  • HTA78 Strategic Roadmap for Successful Market Penetration in the Dynamic Central and Eastern Europe: Prospect for US/Global Companies?

    Jun 1, 2024, 00:00

  • EE165 A Cost-Consequence Analysis of Ponatinib Versus Imatinib in Patients with Newly Diagnosed Philadelphia-Positive Acute Lymphoblastic Leukemia in the United States

    Jun 1, 2024, 00:00

  • Epidemiology Public Health

    Jun 1, 2024, 00:00

  • PCR21 The Impact of Fathers' Supportive Role, Mood State Changes on Long-Term Breastfeeding in the Postpartum Period

    Jun 1, 2024, 00:00

  • EPH58 Changes in the Number of Different Categories of Specialists in Europe

    Jun 1, 2024, 00:00

  • HSD107 Out-of-Pocket Health Care Spending Among Medicare Beneficiaries by Sex, Age, and Race/Ethnicity

    Jun 1, 2024, 00:00

  • HPR87 Assessing the Implementability of Regulatory Agencies’ Guidance on Diversity in Clinical Trials

    Jun 1, 2024, 00:00

  • HTA53 Advances in Science and Challenges at HTA: The Case of CRISPR Technologies

    Jun 1, 2024, 00:00

  • EPH214 Impact of Preoperative Anxiety and Depression on Chronic Postoperative Opioid Use in Orthopedic Surgery Patients

    Jun 1, 2024, 00:00

  • EE357 Using a Computer Vision-Based System for Reading Skin Prick Test Results: A Cost-Minimisation Analysis

    Jun 1, 2024, 00:00

  • PCR40 Evaluating the Evolution of Patient-Reported Outcome Measures (PROMs) in Health Technology Assessments: A Focus on Neurological Diseases in NICE Technology Appraisals

    Jun 1, 2024, 00:00

  • RWD113 Comparative Analysis of Vaping Use Disorder (VUD) and CDC Proxy Codes: A Demographic Perspective

    Jun 1, 2024, 00:00

  • EPH98 Association Between Social Vulnerability and Opioid Dispensing By Contiguous County in the United States

    Jun 1, 2024, 00:00

  • EE359 Economic Burden of Managing Acute and Chronic Pain in the United States: National Estimates from 2022 Data

    Jun 1, 2024, 00:00

  • RWD82 Treatment Patterns of Ulcerative Colitis and Crohn's Disease Patients in Taiwan: A National Health Insurance Research Database (NHIRD) Study

    Jun 1, 2024, 00:00

  • PCR144 Generating Uptake Probabilities from Discrete-Choice Experiment-Derived Preferences for Application in Patient-Centered Value Assessment

    Jun 1, 2024, 00:00

  • CO37 Real-World Treatment Patterns, Healthcare Resource Utilization (HCRU) and Clinical Outcomes of Patients with Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) in Alberta, Canada

    Jun 1, 2024, 00:00

  • RWD129 Trends in GLP-1 Receptor Agonist Dispensing Among US Patients Without Type 2 Diabetes Using Real World Data

    Jun 1, 2024, 00:00

  • CO110 Physical Examination of the Functional Status of the Hip and Spine in Junior Swimmers and Synchronised Swimmers

    Jun 1, 2024, 00:00

  • EPH54 Enhancing BMI Data Accuracy: A Comparison of Claims and Electronic Health Records (EHR) Database

    Jun 1, 2024, 00:00

  • EPH67 Incidence of Mortality and the Impact of Malnutrition on Chronic Kidney Disease Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis

    Jun 1, 2024, 00:00

  • HSD48 US Infusion Center Capacity to Accommodate Anti-Amyloid Treatments for Alzheimer’s Disease: A Quantitative Survey

    Jun 1, 2024, 00:00

  • EE362 Analysis of the Cost of Pharmacological Care for Patients With Type 2 Diabetes Mellitus on the Colombian Atlantic Coast: 2019-2022 Risk Cohort Analysis

    Jun 1, 2024, 00:00

  • PT19 Developing a Bespoke Neural Network Model for Diagnosing Alzheimer's Dementia: A Fit-for-Purpose Machine Learning Study

    Jun 1, 2024, 00:00

  • PCR139 Beneficial Effect of Physical Activity on Pain-Related Self-Efficacy Among Women with Endometriosis and Chronic Pelvic Pain, Cross-Sectional Study

    Jun 1, 2024, 00:00

  • CO124 Association Between Quality of Life and Viral Load Among People With HIV in the Current Antiretroviral Era

    Jun 1, 2024, 00:00

  • RWD167 Clinical Utilization of Sodium-Glucose Cotransporter 2 Inhibitors in Systolic and Diastolic Heart Failure at a Large Academic Hospital

    Jun 1, 2024, 00:00

  • EE326 Health Care Resource Utilization and Costs Among Patients with Paroxysmal Nocturnal Hemoglobinuria Initiating Eculizumab and Ravulizumab: A U.S. Claims Analysis

    Jun 1, 2024, 00:00

  • CO5 Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Cancer: A Target Trial Emulation From SEER-Medicare Database

    Jun 1, 2024, 00:00

  • EE64 Treatment-Related Costs of Ponatinib and Asciminib in Adults Patients with T315I-Positive Chronic Phase Chronic Myeloid Leukemia with Resistance or Intolerance to at Least Two Prior Kinase Inhibitors in the United States

    Jun 1, 2024, 00:00

  • CO140 Heterogeneous Treatment Effects of an Intensive Lifestyle Intervention: Evidence From the Look Ahead Study

    Jun 1, 2024, 00:00

  • HSD47 Treatment Response, Healthcare Resource Use, and Economic Outcomes Associated With Tumor Necrosis Factor Inhibitor Cycling Versus Switching to an Advanced Therapy With Different Mechanism of Action in Rheumatoid Arthritis

    Jun 1, 2024, 00:00

  • EE236 Healthcare Resource Utilization (HCRU) and Direct Medical Costs Following Acute SARS-Cov-2 Infection: Findings From a Literature Review

    Jun 1, 2024, 00:00

  • EE340 Real-World Healthcare Resource Utilization and Costs of Patients with Alzheimer’s Disease By Stage: A Retrospective Observational Study

    Jun 1, 2024, 00:00

  • RWD189 Exploration of Reason Codes in Real World Cardiovascular System Short-Term Disability Claims in the United States

    Jun 1, 2024, 00:00

  • EE335 Burden of Disease in Patients Who Are Eligible for Bcma-Targeted Immunotherapy for Multiple Myeloma: A Retrospective Claims Database Analysis

    Jun 1, 2024, 00:00

  • EE401 Unlocking the Economic Potential of Digital Health Interventions in Cardiovascular and Metabolic Diseases

    Jun 1, 2024, 00:00

  • RWD144 Predictive Risk Score for Nonalcoholic Steatohepatitis (NASH) Among Patients in the Department of Defense Population

    Jun 1, 2024, 00:00

  • EE491 Modeling Costs of Variations in Healthcare Utilization Following the COVID-19 Pandemic: Exploring How Model Choices and Fit Impact Interpretation

    Jun 1, 2024, 00:00

  • HPR61 Impact of Changes in US Medicaid Reimbursement for Long-Acting Reversible Contraceptives in the Immediate Postpartum Period

    Jun 1, 2024, 00:00

  • PCR115 Health States Utilities for Allergic Rhinitis - an AI-Supported Systematic Review

    Jun 1, 2024, 00:00

  • CO84 Racial/Ethnic Differences in Healthcare Resource Utilization Among Patients With Amyotrophic Lateral Sclerosis in Texas

    Jun 1, 2024, 00:00

  • PCR164 Exploring Symptom Burden, Treatment Bother, Physical Function, and Quality of Life By Frailty Status in Patients with Colorectal Cancer (CRC)

    Jun 1, 2024, 00:00

  • RWD147 Quantifying the Effectiveness of a RWD Quality Framework: A Case Study Using Paroxysmal Nocturnal Hemoglobinuria (PNH)

    Jun 1, 2024, 00:00

  • CO189 Preliminary Outcomes of a Hearing Loss Screening Program of 5,360 Older Adults at the Medical University of South Carolina

    Jun 1, 2024, 00:00

  • PCR151 Understanding the Patient Perspectives of Post-Discharge Care and Impact of Treatment in the First Year Post-Acute Myocardial Infarction

    Jun 1, 2024, 00:00

  • EE94 End-of-Life Costs Among Older Adults Living with HIV

    Jun 1, 2024, 00:00

  • EPH35 Self-Reported Hypertension and the Likelihood of Aspirin Use and Associated Adverse Effects Among Adults Aged 18 Years and Older

    Jun 1, 2024, 00:00

  • MSR12 Use of Single Arm Studies/Disconnected Observational Studies in Comparative Effectiveness of Treatments for Fabry Disease: A Network Meta-Analysis Using a 3-Level Hierarchical Model

    Jun 1, 2024, 00:00

  • PT1 Incorporating Stakeholder Perspectives Into Open-Source Model Building for Major Depressive Disorder

    Jun 1, 2024, 00:00

  • HSD86 Health Care Utilization before and during the COVID-19 Pandemic in Patients with Epithelial Ovarian Cancer

    Jun 1, 2024, 00:00

  • RWD37 Demographic, Chronic Disease, and Health Care Utilization Characteristics of Patients Self-Reporting Economic Insecurity in a Large Midwest Health System

    Jun 1, 2024, 00:00

  • SA71 Evaluation of Disease Burden (COMORBIDITIES, LENGTH OF HOSPITALIZATION AND HEALTHCARE RESOURCE UTILIZATION) from Respiratory Syncytial Virus (RSV) Illness in United Arab Emirates: A Retrospective Cohort Claims Database Study

    Jun 1, 2024, 00:00

  • HPR112 Variation in Coverage of Specialty Therapies and Barriers to Fair Access

    Jun 1, 2024, 00:00

  • PCR19 Content-Related Validity of the Rand-36 Composite Scores with Other Patient-Reported Outcome Scales Among National Health and Wellness Survey Respondents in the United States, Japan, and 5 European Countries

    Jun 1, 2024, 00:00

  • MSR94 A Flexible, Likelihood-Based Method for Estimating Underlying Distributions, Mean and SD-Based on Reported Quantiles Such as Median and Inter-Quartile Range

    Jun 1, 2024, 00:00

  • RWD73 Repurposing Statins to Reduce the Risk of Alzheimer's Disease and Related Dementias: A Machine Learning Approach for Causal Estimates

    Jun 1, 2024, 00:00

  • EPH39 A Targeted Literature Review (TLR) of Clinical, Humanistic, and Economic Burden of Alzheimer’s Disease (AD) in the United States (US)

    Jun 1, 2024, 00:00

  • EPH148 Bridging the Gap: Understanding Prostate Cancer Patient Characteristics in Clinical Trials

    Jun 1, 2024, 00:00

  • HPR41 One Step Away From the Abyss? Analysis of the Supplementary Health System in Brazil

    Jun 1, 2024, 00:00

  • Novel Outcomes Research Data Methods

    Jun 1, 2024, 00:00

  • CO209 Comorbidities in Myasthenia Gravis in the US National Veterans Affairs Health Network.

    Jun 1, 2024, 00:00

  • RWD106 Psychological Burden in People Living with Myasthenia Gravis: Prevalence and Associated Risk Factors of Depression and Anxiety from the MGFA Global MG Patient Registry (MGFAPR) in the US (2017-2022)

    Jun 1, 2024, 00:00

  • EE452 Prevalence, Real-World Healthcare Resource Utilization, and Costs of Patients With Paroxysmal Nocturnal Hemoglobinuria in the US: A Retrospective Claims Database Analysis

    Jun 1, 2024, 00:00

  • EE124 Real-World Mental Health Burden in Patients With Chronic Lymphocytic Leukemia

    Jun 1, 2024, 00:00

  • PCR114 Young People’s Barriers and Facilitators of Engagement With Web-Based Mental Health Interventions for Anxiety and Depression: A Qualitative Study

    Jun 1, 2024, 00:00

  • CO126 Competing Risks of Death in Older Adults With Advanced Non-Small Cell Lung Cancer Receiving Programmed Cell Death Protein 1 (PD-1) Inhibitors

    Jun 1, 2024, 00:00

  • EE363 Economic Value of Early Genetic Testing in Inherited Retinal Dystrophy Diagnosis

    Jun 1, 2024, 00:00

  • HSD23 Preferences and Attitudes of Healthcare Providers (HCPs) and Adult Healthcare Consumers (HCCs) Towards Pneumococcal Conjugate Vaccines (PCVs) in the United States (US)

    Jun 1, 2024, 00:00

  • PCR262 The Use of Artificial Intelligence Chat To Improve Readability of Patient-Facing Materials

    Jun 1, 2024, 00:00

  • PCR131 Treatment Continuity, Adverse Events and Psychiatric Hospitalization for Incident Users of Second-Generation Antipsychotics Long-Acting Injections in Schizophrenia: One-Year Follow-up Study

    Jun 1, 2024, 00:00

  • RWD191 Real-World Ovarian Cancer Mortality Outcomes in a Brazilian Reference Women Healthcare Public Hospital

    Jun 1, 2024, 00:00

  • PCR33 Study of the Effects of a 12 Week Functional Exercise Programme in the Hungarian Adult Population

    Jun 1, 2024, 00:00

  • Clinical Outcomes

    Jun 1, 2024, 00:00

  • EE467 Estimation of Budget Impact With the Substitution of Biologic Reference Product for Biosimilars in Patients With Rheumatoid Arthritis From the Perspective of Medium Size Healthcare Insurance in Brazil

    Jun 1, 2024, 00:00

  • HSD115 Rates of Follow-up Colonoscopy After Positive Stool-Based Screening Test for Colorectal Cancer

    Jun 1, 2024, 00:00

  • EPH75 Herpes Zoster Risk Among Immunocompromised Adults in the United States: A Retrospective Cohort Analysis

    Jun 1, 2024, 00:00

  • PT35 Cost-Effectiveness Analysis of Nivolumab Versus Docetaxel for the Treatment of Advanced Nonsquamous NSCLC Including PD-L1 Testing in the United States

    Jun 1, 2024, 00:00

  • CO122 Real-World Data on Inequity in Clinical Outcomes Among Adult Patients Diagnosed with Hypertrophic Cardiomyopathy

    Jun 1, 2024, 00:00

  • HPR148 Identifying and Addressing Social Determinants of Health: A Health System Specialty Pharmacy Approach

    Jun 1, 2024, 00:00

  • CO57 Impact of Coexisting Mental Illnesses and Chronic Conditions on Healthcare Utilization and Cost at Blue Cross and Blue Shield of Louisiana

    Jun 1, 2024, 00:00

  • EPH22 Epidemiology and Treatment Patterns of Colombian Patients With Metastatic Colorectal

    Jun 1, 2024, 00:00

  • RWD66 Lung Cancer Chemotherapy-Associated Clostridium Difficile Infection Among Elderly Patients in the United States

    Jun 1, 2024, 00:00

  • HSD71 Implementing Patient-Reported Outcomes in Clinical Practi The PROTEUS-Practice Framework Guide

    Jun 1, 2024, 00:00

  • MT14 Assessing the Association Between Cardiovascular Acoustic Biomarkers and Heart Failure: A Systematic Literature Review

    Jun 1, 2024, 00:00
  • «
  • 11 (current)
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • »